Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
451,871
Value
$25.9M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026451,871$25.9M<0.1%−573,000−55.9%ReducedHolders
Q1 20261,024,871$57.9M0.1%−300,100−22.6%ReducedHolders
Q4 20251,324,971$78.7M0.1%−568,600−30.0%ReducedHolders
Q3 20251,893,571$102.6M0.1%+86,800+4.8%AddedHolders
Q2 20251,806,771$99.3M0.1%+911,000+101.7%AddedHolders
Q1 2025895,771$63.3M0.1%+459,900+105.5%AddedHolders
Q4 2024435,871$28.6M<0.1%+17,000+4.1%AddedHolders
Q3 2024418,871$29.4M<0.1%+302,671+260.5%AddedHolders
Q2 2024116,200$9.57M<0.1%−425,871−78.6%ReducedHolders
Q1 2024542,071$47.3M0.1%+155,400+40.2%AddedHolders
Q4 2023386,671$37.3M0.1%−195,100−33.5%ReducedHolders
Q3 2023581,771$51.5M0.1%−150,867−20.6%ReducedHolders
Q2 2023732,638$63.5M0.1%−48,433−6.2%ReducedHolders
Q1 2023781,071$76.0M0.1%+150,800+23.9%AddedHolders
Q4 2022630,271$65.2M0.1%−114,200−15.3%ReducedHolders
Q3 2022744,471$63.1M0.1%+9,708+1.3%AddedHolders
Q2 2022734,763$60.9M0.1%+243,592+49.6%AddedHolders
Q1 2022491,171$37.9M<0.1%−159,889−24.6%ReducedHolders
Q4 2021651,060$57.5M0.1%+269,589+70.7%AddedHolders
Q3 2021381,471$29.5M<0.1%+91,500+31.6%AddedHolders
Q2 2021289,971$24.2M<0.1%−75,600−20.7%ReducedHolders
Q1 2021365,571$27.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.